Key result
Antecedent epinephrine infusion before endotoxin reduced inflammatory cytokine responses (P<0.01) but further reduced parameters of heart rate variability measuring vagal activity (P<0.05).
Why the study?
Does antecedent epinephrine infusion reduce endotoxin-induced changes in heart rate variability in healthy volunteers?
RCT (n=17)
Does antecedent epinephrine infusion reduce endotoxin-induced changes in heart rate variability in healthy volunteers?
p-value: p=<0.05
Antecedent epinephrine infusion attenuates the pro-inflammatory response to endotoxin but further reduces vagal activity and heart rate variability.
Antecedent epinephrine attenuates endotoxin inflammation yet further impairs vagal HRV; extends mechanistic catecholamine-immune data but leaves clinical translation open.
In Brief Objective: To determine whether the acute anti-inflammatory influence of epinephrine (EPI) extends to changes in heart rate variability (HRV) induced by the prototypical inflammatory stimulus, endotoxin (lipopolysaccharide [LPS]). Summary Background Data: HRV reflects fluctuating cardiac autonomic inputs and is acutely reduced during the systemic inflammation induced by LPS as well as during severe critical illnesses such as sepsis and traumatic injury. While EPI may diminish proinflammatory cytokine release, it is unknown whether this net anti-inflammatory activity extends to HRV. Methods: Healthy volunteers (n = 17) were randomized to either saline + LPS (2 ng/kg) or LPS + antecedent EPI infusion (30 ng/kg/min) from −3 to 6 hours relative to LPS. HRV and blood samples were obtained before EPI and LPS as well as hourly afterward. Plasma cytokines were measured by ELISA. Statistical analysis was by repeated measures analysis of variance. This study was registered at Clinicaltrials.gov and is listed under the following ID number: NCT00753402. Results: LPS acutely influenced all measured parameters of HRV including standard deviation of the average beat to beat intervals over a 5-minute period, percentage of interval differences of successive interbeat intervals greater than 50 milliseconds and square root of the mean squared differences, high frequency (HF), low frequency, low frequency/HF, and very low frequency (all P < 0.01). EPI infusion reduced the inflammatory cytokine response to LPS as measured by decreased TNFα, IL-6, and IL-8 (P < 0.01). Relative to the saline + LPS group, antecedent EPI infusion was associated with further reductions in parameters of HRV measuring vagal/parasympathetic activity including, percentage of interval differences of successive interbeat intervals greater than 50 milliseconds, square root of the mean squared differences, and HF (P < 0.05). Conclusion: Prior EPI exposure exerts anti-inflammatory influences but also may reduce vagus nerve activity. Hence, acute EPI administration may be protective against early inflammatory challenges but diminish vagal nerve responsiveness to subsequent stimuli. Epinephrine infusion attenuates the pro-inflammatory mediator response to a subsequent ligand, such as endotoxin, in humans. Diminished heart rate variability is also induced by endotoxin and we evaluated whether epinephrine I also influences heart rate variability responses. Epinephrine before endotoxin was associated with significantly reduced vagal activity. These findings may have implications for conditions of prolonged adrenergic stress.
No takes yet. Share an insight, caveat, or question.
Jan et al. (2009) conducted an RCT in Healthy volunteers (endotoxin-induced systemic inflammation) (n=17). Epinephrine (EPI) infusion + LPS vs. Saline + LPS (2 ng/kg) was evaluated on Heart rate variability (HRV) parameters and plasma cytokines (p=<0.05). Antecedent epinephrine infusion before endotoxin reduced inflammatory cytokine responses (P<0.01) but further reduced parameters of heart rate variability measuring vagal activity (P<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: